Rare diseases
Investigational molecules
Locations
328 conditions with trials, the busiest first
865 trials across Europe, recruiting first
Study on the Safety of VX-670 for Adults with Myotonic Dystrophy Type 1
BelgiumStudy on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers
GermanyStudy on Corticosteroids and Rituximab to Prevent Worsening of Ocular Myasthenia Gravis in Newly Diagnosed Patients
FranceStudy Comparing Corticosteroid Injection and Arthrocentesis for Temporomandibular Joint Arthritis in Patients Using Methylprednisolone Acetate and Lidocaine Hydrochloride
DenmarkStudy of Sodium Thiosulfate Injections for Patients with Ectopic Calcifications or Ossifications from Dermatomyositis, Systemic Sclerosis, or iPPSD2
FranceStudy of Denosumab Effects on Muscle Strength and Insulin Sensitivity in Patients with Postmenopausal Osteoporosis and Diabetes Mellitus
DenmarkStudy on Tislelizumab for Cancer Patients with Molecular Residual Disease After Standard Treatment
FranceStudy on Denosumab for Treating Fibrous Dysplasia/McCune-Albright Syndrome in Adults
The NetherlandsStudy on Low-Dose Aldesleukin for Patients with Pemphigus, Mucous Membrane Pemphigoid, Polymyositis, Dermatomyositis, and Primary Sclerosing Cholangitis
GermanyStudy on the Safety and Effectiveness of Baricitinib for Children Aged 1 to 17 with Juvenile Idiopathic Arthritis
AustriaStudy of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas
FranceStudy on CART45RA-NKG2D Cells for Children, Adolescents, and Young Adults with Advanced Sarcoma
SpainThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
